loadpatents
name:-0.025998830795288
name:-0.017924785614014
name:-0.0026180744171143
Morgan; Timothy Matthias Patent Filings

Morgan; Timothy Matthias

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morgan; Timothy Matthias.The latest application filed is for "intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders".

Company Profile
2.18.24
  • Morgan; Timothy Matthias - Warrnambool AU
  • Morgan; Timothy Matthias - Victoria AU
  • Morgan; Timothy Matthias - Carlton North AU
  • Morgan; Timothy Matthias - Melbourne N/A AU
  • Morgan; Timothy Matthias - Parkville AU
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Intranasal Compositions For Treatment of Neurological And Neurodegenerative Diseases And Disorders
App 20210145789 - Morgan; Timothy Matthias
2021-05-20
Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders
Grant 10,933,045 - Morgan March 2, 2
2021-03-02
Intranasal Compositions For Treatment of Neurological And Neurodegenerative Diseases And Disorders
App 20200078331 - Morgan; Timothy Matthias
2020-03-12
Intranasal compositions for treatment of neurological and neurodegenerative diseases and disorders
Grant 10,471,040 - Morgan Nov
2019-11-12
Intranasal Compositions For Treatment of Neurological And Neurodegenerative Diseases And Disorders
App 20170239209 - Morgan; Timothy Matthias
2017-08-24
Transdermal Delivery Rate Control Using Amorphous Pharmaceutical Compositions
App 20150094290 - Morgan; Timothy Matthias ;   et al.
2015-04-02
Transdermal delivery rate control using amorphous pharmaceutical compositions
Grant 8,784,878 - Morgan , et al. July 22, 2
2014-07-22
Transdermal Delivery Rate Control Using Amorphous Pharmaceutical Compositions
App 20130316996 - Morgan; Timothy Matthias ;   et al.
2013-11-28
Home diagnostic system
Grant 8,388,532 - Morgan March 5, 2
2013-03-05
Transdermal delivery rate control using amorphous pharmaceutical compositions
Grant 8,357,393 - Morgan , et al. January 22, 2
2013-01-22
Dermal penetration enhancers and drug delivery systems involving the same
Grant 8,071,075 - Reed , et al. December 6, 2
2011-12-06
Transdermal Delivery Rate Control Using Amorphous Pharmaceutical Compositions
App 20100166674 - Morgan; Timothy Matthias ;   et al.
2010-07-01
Dermal penetration enhancers and drug delivery systems involving same
Grant 7,438,203 - Reed , et al. October 21, 2
2008-10-21
Method and System for Rapid Transdermal Administration
App 20080226699 - Finnin; Barrie Charles ;   et al.
2008-09-18
Dermal penetration enhancers and drug delivery systems involving the same
App 20080152597 - Reed; Barry Lenard ;   et al.
2008-06-26
Transdermal delivery of non-steroidal anti-inflammatory drugs
Grant 7,387,789 - Klose , et al. June 17, 2
2008-06-17
Dermal Penetration enhancers and drug delivery systems involving same
App 20080131494 - Reed; Barry Lenard ;   et al.
2008-06-05
Method and Composition for Treatment of Cutaneous Lesions
App 20080027033 - Gonda; Igor ;   et al.
2008-01-31
Cap With Seal Moved By Rotatable Collar And Receptacle With Spreading Surface
App 20070293842 - Knight; Barry ;   et al.
2007-12-20
Method and Composition for Treatment or Prophylaxis of Amyloidosis Disorders
App 20070275943 - Morgan; Timothy Matthias ;   et al.
2007-11-29
Transdermal delivery of non-steroidal anti-inflammatory drugs
App 20070077288 - Klose; Kathryn Traci-Jane ;   et al.
2007-04-05
Dermal penetration enhancers and drug delivery systems involving same
App 20070071803 - Reed; Barry Leonard ;   et al.
2007-03-29
Topical delivery of antifungal agents
Grant 7,094,422 - Chew , et al. August 22, 2
2006-08-22
Topical delivery of anti-alopecia agents
Grant 6,998,138 - Chew , et al. February 14, 2
2006-02-14
Transdermal delivery of antianxiety agents
Grant 6,964,777 - Klose , et al. November 15, 2
2005-11-15
Transdermal aerosol compositions
App 20050186141 - Gonda, Igor ;   et al.
2005-08-25
Metastable pharmaceutical compositions
App 20050181032 - Wilkins, Nina Frances ;   et al.
2005-08-18
Transdermal delivery of hormones
Grant 6,923,983 - Morgan , et al. August 2, 2
2005-08-02
Transdermal delivery of analgesics
Grant 6,916,486 - Klose , et al. July 12, 2
2005-07-12
Transdermal delivery of antiemetics
Grant 6,916,487 - Klose , et al. July 12, 2
2005-07-12
Dermal penetration enhancers and drug delivery systems involving same
Grant 6,818,226 - Reed , et al. November 16, 2
2004-11-16
Dermal penetration enhancers and drug delivery systems involving same
App 20040146469 - Reed, Barry Lenard ;   et al.
2004-07-29
Topical delivery of anti-alopecia agents
App 20040096405 - Chew, Nora Yat Knork ;   et al.
2004-05-20
Topical delivery of antifungal agents
App 20040081684 - Chew, Nora Yat Knork ;   et al.
2004-04-29
Transdermal delivery of analgesics
App 20040028625 - Klose, Kathryn Traci-Jane ;   et al.
2004-02-12
Transdermal delivery of hormones
App 20040028725 - Morgan, Timothy Matthias ;   et al.
2004-02-12
Transdermal delivery of antiemetics
App 20040013621 - Klose, Kathryn Traci-Jane ;   et al.
2004-01-22
Transdermal delivery of antianxiety agents
App 20040009214 - Klose, Kathryn Traci-Jane ;   et al.
2004-01-15
Dermal penetration enhancers and drug delivery systems involving same
App 20020028235 - Reed, Barry Leonard ;   et al.
2002-03-07
Dermal penetration enhancers and drug delivery systems involving same
Grant 6,299,900 - Reed , et al. October 9, 2
2001-10-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed